Keith E. Anderson
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Keith E. Anderson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Extinct | Biotechnology | 42 | |
| Public Company | Pharmaceuticals: Major | 26 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Keith E. Anderson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | General Counsel Director/Board Member | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Sales & Marketing Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Investor | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer Chief Operating Officer Public Communications Contact | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ORGANOVO HOLDINGS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| University of Utah | College/University | Graduate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree | |
| Queen's University | College/University | Masters Business Admin Graduate Degree | |
| San Diego State University | College/University | Undergraduate Degree Graduate Degree | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| University of British Columbia | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| Simon Fraser University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| LaTrobe University | College/University | Masters Business Admin Masters Business Admin | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Sales & Marketing | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| OMNIAB, INC. | Miscellaneous Commercial Services | General Counsel Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 39 |
| Canada | 8 |
| Regno Unito | 4 |
| Australia | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Finance | 6 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 306 |
| Corporate Officer/Principal | 135 |
| Independent Dir/Board Member | 110 |
| Chief Tech/Sci/R&D Officer | 60 |
| Undergraduate Degree | 55 |
Contatti più connessi
| Insiders | |
|---|---|
| James Topper | 49 |
| Peter Thompson | 39 |
| Donald Parfet | 31 |
| Albert Cha | 30 |
| Daniel Loeb | 26 |
| Paul Maier | 25 |
| John Kozarich | 21 |
| Gaurav Aggarwal | 21 |
| Jason Aryeh | 18 |
| Georgia Erbez | 18 |
| Andrew Allen | 18 |
| Craig Collard | 18 |
| Nicole Onetto | 17 |
| Angie You | 15 |
| Stephen Dilly | 15 |
- Borsa valori
- Insiders
- Keith E. Anderson
- Connessioni Società
